Millipore Sigma Vibrant Logo
Attenzione: Ci siamo trasferiti. Non è più possibile acquistare i prodotti Merck Millipore nel sito MerckMillipore.comPer saperne di più

MAB1345 Anti-Collagen Type VII Antibody, CT, clone LH7.2

MAB1345
200 µL  
Purchase on Sigma-Aldrich

Offerte speciali

Panoramica

Replacement Information

Offerte speciali

Tabella delle specifiche principali

Species ReactivityKey ApplicationsHostFormatAntibody Type
HICCMAscitesMonoclonal Antibody
Description
Catalogue NumberMAB1345
Brand Family Chemicon®
Trade Name
  • Chemicon
DescriptionAnti-Collagen Type VII Antibody, CT, clone LH7.2
References
Product Information
FormatAscites
PresentationAscites. Liquid with 0.1% sodium azide.
Quality LevelMQ100
Applications
ApplicationAnti-Collagen Type VII Antibody, C-terminus, clone LH7.2 is an antibody against Collagen Type VII for use in IC.
Key Applications
  • Immunocytochemistry
Application NotesImmunohistochemistry.

Optimal working dilutions must be determined by end user.
Biological Information
ImmunogenCollagen type VII.
EpitopeC-terminus
CloneLH7.2
HostMouse
SpecificityCarboxy terminal peptide of type VII collagen.
IsotypeIgG
Species Reactivity
  • Human
Antibody TypeMonoclonal Antibody
Entrez Gene Number
Entrez Gene SummaryThis gene encodes the alpha chain of type VII collagen. The type VII collagen fibril, composed of three identical alpha collagen chains, is restricted to the basement zone beneath stratified squamous epithelia. It functions as an anchoring fibril between the external epithelia and the underlying stroma. Mutations in this gene are associated with all forms of dystrophic epidermolysis bullosa. In the absence of mutations, however, an acquired form of this disease can result from an autoimmune response made to type VII collagen.
Gene Symbol
  • COL7A1
  • EBR1
  • EBD1
  • EBDCT
UniProt Number
UniProt SummaryFUNCTION: SwissProt: Q02388 # Stratified squamous epithelial basement membrane protein that forms anchoring fibrils which may contribute to epithelial basement membrane organization and adherence by interacting with extracellular matrix (ECM) proteins such as type IV collagen.
SIZE: 2944 amino acids; 295220 Da
SUBUNIT: Homotrimer.
SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix, basement membrane.
PTM: Prolines at the third position of the tripeptide repeating unit (G-X-Y) are hydroxylated in some or all of the chains.
DISEASE: SwissProt: Q02388 # Epidermolysis bullosa acquisita (EBA) is an autoimmune acquired blistering skin disease resulting from autoantibodies to type VII collagen. & Defects in COL7A1 are the cause of dystrophic epidermolysis bullosa (DEB) [MIM:131750, 226600]. DEB is a group of blistering skin diseases with either autosomal dominant or autosomal recessive inheritance. Ultrastructurally, DEB is characterized by tissue separation which occurs below the dermal- epidermal basement membrane at the level of the anchoring fibrils. Various clinical types with different severity are recognized. DEB Pasini type is a severe, dominantly inherited form. Among the recessively inherited forms, the Hallopeau-Siemens type epidermolysis bullosa is the most severe form. It manifests with mutilating scarring, joint contractures, corneal erosions, esophagus structures, and propensity to formation of cutaneous squamous cell carcinomas leading to premature demise of the affected individuals. Two milder recessive forms are dystrophic epidermolysis bullosa mitis type and the localized type. The mitis type shows lifelong blistering tendency, with limited scarring and less frequent extracutaneous manifestations. In the localized type, blistering and scarring are predominantly localized to the extremities. & Defects in COL7A1 are the cause of transient bullous dermolysis of the newborn (TBDN) [MIM:131705]. TBDN is a neonatal skin blistering disorder with features similar to those observed in dystrophic epidermolysis bullosa. TBDN is characterized by sub- epidermal blisters, reduced or abnormal anchoring fibrils at the dermo-epidermal junction, and electron-dense inclusions in keratinocytes. TBDN heals spontaneously or strongly improves within the first months and years of life. & Defects in COL7A1 are the cause of pretibial type dystrophic epidermolysis bullosa (P-DEB) [MIM:131850]. Inheritance is autosomal dominant. & Defects in COL7A1 are the cause of Bart type dystrophic epidermolysis bullosa (B-DEB) [MIM:132000]; also known as epidermolysis bullosa with congenital localized absence of skin and deformity of nails. Inheritance is autosomal dominant. & Defects in COL7A1 are the cause of epidermolysis bullosa pruriginosa (EBP) [MIM:604129]. EBP is a distinct clinical subtype of DEB. It is characterized by skin fragility, blistering, scar formation, intense pruritus and excoriated prurigo nodules. Onset is in early childhood, but in some cases is delayed until the second or third decade of life. Inheritance can be autosomal dominant or recessive. & Defects in COL7A1 are the cause of isolated toenail dystrophy without skin fragility [MIM:607523]. & Defects in COL7A1 are the cause of epidermolysis bullosa dystrophica with subcorneal cleavage (EBDSC) [MIM:607600]; also known as epidermolysis bullosa simplex superficialis (EBSS). EBDSC is a new variant of epidermolysis bullosa simplex (EBS), characterized by the development of skin cleavage just beneath the level of stratum corneum. It appears to be transmitted as an autosomal dominant trait and differs from other autosomal dominant forms of EBS by the common findings of milia and atrophic scarring, as well as involvement of oral and/or ocular surfaces. It is further differentiated by the presence of blisters and the absence of spontaneous continual exfoliation or peeling.
SIMILARITY: SwissProt: Q02388 ## Contains 1 BPTI/Kunitz inhibitor domain. & Contains 9 fibronectin type-III domains. & Contains 2 VWFA domains.
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsMaintain at -20°C in convenient aliquots for up to 12 months. Avoid repeated freeze/thaw cycles.
Packaging Information
Material Size200 µL
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Numero di catalogo GTIN
MAB1345 04053252319099

Documentation

Anti-Collagen Type VII Antibody, CT, clone LH7.2 MSDS

Titolo

Scheda di sicurezza (MSDS) 

Anti-Collagen Type VII Antibody, CT, clone LH7.2 Certificati d'Analisi

TitoloNumero di lotto
MOUSE ANTI-COLLAGEN TYPE VII (HUMAN) MONOCLONAL ANTIBODY - 2436422 2436422
MOUSE ANTI-COLLAGEN TYPE VII (HUMAN) - 2828585 2828585
MOUSE ANTI-COLLAGEN TYPE VII (HUMAN) - 3172116 3172116
MOUSE ANTI-COLLAGEN TYPE VII (HUMAN) - 3496528 3496528
MOUSE ANTI-COLLAGEN TYPE VII (HUMAN) - 3792153 3792153
MOUSE ANTI-COLLAGEN TYPE VII (HUMAN) - 3984048 3984048
MOUSE ANTI-COLLAGEN TYPE VII (HUMAN) - 4097763 4097763
MOUSE ANTI-COLLAGEN TYPE VII (HUMAN) -2705078 2705078
MOUSE ANTI-COLLAGEN TYPE VII (HUMAN) -2736616 2736616
MOUSE ANTI-COLLAGEN TYPE VII (HUMAN) MONOCLONAL ANTIBODY 2914964

Riferimenti bibliografici

Panoramica dei riferimenti bibliograficiCodice d'identificazione nel Pub Med
Novel sutureless keratoplasty with a chemically defined bioadhesive.
Maho Takaoka, Takahiro Nakamura, Hajime Sugai, Adam J Bentley, Naoki Nakajima, Norihiko Yokoi, Nigel J Fullwood, Suong-Hyu Hyon, Shigeru Kinoshita, Maho Takaoka, Takahiro Nakamura, Hajime Sugai, Adam J Bentley, Naoki Nakajima, Norihiko Yokoi, Nigel J Fullwood, Suong-Hyu Hyon, Shigeru Kinoshita, Maho Takaoka, Takahiro Nakamura, Hajime Sugai, Adam J Bentley, Naoki Nakajima, Norihiko Yokoi, Nigel J Fullwood, Suong-Hyu Hyon, Shigeru Kinoshita
Investigative ophthalmology visual science  50  2679-85  2009

Mostra il sommario
19136714 19136714
Novel sutureless transplantation of bioadhesive-coated, freeze-dried amniotic membrane for ocular surface reconstruction.
Sekiyama, E; Nakamura, T; Kurihara, E; Cooper, LJ; Fullwood, NJ; Takaoka, M; Hamuro, J; Kinoshita, S
Investigative ophthalmology & visual science  48  1528-34  2007

Mostra il sommario
17389481 17389481
The quantification of hCLCA2 and colocalisation with integrin beta4 in stratified human epithelia.
Connon, Che J, et al.
Acta Histochem., 106: 421-5 (2005)  2004

Mostra il sommario
15707651 15707651
Vitamin C regulates keratinocyte viability, epidermal barrier, and basement membrane in vitro, and reduces wound contraction after grafting of cultured skin substitutes.
Boyce, ST; Supp, AP; Swope, VB; Warden, GD
The Journal of investigative dermatology  118  565-72  2002

Mostra il sommario
11918700 11918700
Immunohistochemical characterization of intact stromal layers in long-term cultures of human bone marrow.
Wilkins, B S and Jones, D B
Br. J. Haematol., 90: 757-66 (1995)  1994

Mostra il sommario
7669654 7669654

Prodotti e applicazioni correlate

Related Products

Numero di catalogo Descrizione
MAB2500 Anti-Collagen Type VII Antibody, clone 32,-VII

Linee di prodotti

Categorie

Life Science Research > Antibodies and Assays > Primary Antibodies